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Background: Stress granules (SGs) are granular aggregates in the cytoplasm that are formed under a variety of
stress situations including viral infection. Previous studies indicate that poliovirus, a member of Picornaviridae, can
induce SG formation. However, the exact mechanism by which the picornaviruses induce SG formation is unknown.
Method: The localization of SG markers in cells infected with coxsackievirus B3 (CVB3) or enterovirus 71 (EV71) and
in cells expressing each viral protein was determined via immunofluorescence assays or plasmid transfection. Eight
plasmids expressing mutants of the 2A protease (2Apro) of CVB3 were generated using a site-directed mutagenesis
strategy. The cleavage efficiencies of eIF4G by CVB3 2Apro and its mutants were determined via western blotting
assays.
Results: In this study, we found that CVB3 infection induced SG formation, as evidenced by the co-localization of
some accepted SG markers in viral infection-induced granules. Furthermore, we identified that 2Apro of CVB3 was
the key viral component that triggered SG formation. A 2Apro mutant with the G122E mutation, which exhibited
very low cleavage efficiency toward eIF4G, significantly attenuated its capacity for SG induction, indicating that the
protease activity was required for 2Apro to initiate SG formation. Finally, we observed that SGs also formed in
EV71-infected cells. Expression of EV71 2Apro alone was also sufficient to cause SG formation.
Conclusion: Both CVB3 and EV71 infections can induce SG formation, and 2Apro plays a crucial role in the induction of
SG formation during these infections. This finding may help us to better understand how picornaviruses initiate the SG
response.
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Stress granules (SGs) are granular aggregates formed in
the cytoplasm of eukaryotic cells exposed to a variety of
environmental stress conditions, e.g., heat shock, UV ir-
radiation, hypoxia, endoplasmic reticulum stress, and viral
infection [1,2]. SGs typically contain translationally silent
mRNAs, 40S ribosomal subunits, eukaryotic initiation
factors (eIFs) such as eIF4E, eIF4G, eIF4A, eIF4B, eIF3,
and eIF2, and RNA-binding proteins (RBPs), including* Correspondence: zhaowr@ems.hrbmu.edu.cn; zhongzh@hrbmu.edu.cn
2Department of Cell Biology, Harbin Medical University, Harbin 150081, China
1Department of Microbiology, Harbin Medical University, Harbin 150081,
China
Full list of author information is available at the end of the article
© 2014 Wu et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.poly(A)-binding protein (PABP1), the embryonic lethal
abnormal vision (ELAV) Hu protein (HuR), polysomal
ribonuclease 1 (PMR-1), tristetraprolin (TTP), T-cell-
restricted intracellular antigen 1 (TIA1), TIA-1-related
protein (TIAR), fragile X mental retardation protein
(FMRP), and Ras-Gap SH3-binding protein (G3BP1) [1,2].
Among these recruited proteins, HuR, TIA1, and G3BP1
can act as markers of SGs [1-4].
Numerous viruses have been shown to interact with
SGs with different effects [5-7]. Some viruses induce stable
SG formation during infection, e.g., respiratory syncytial
virus (RSV). Some viruses, e.g., mammalian orthoreo-
viruses (MRV), Semliki Forest viruses (SFV), and hepatitis
C viruses (HCV) have been shown to induce SG. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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proceeds. Poliovirus (PV) induces SG formation early dur-
ing infection and later inhibits SGs through the viral
3Cpro-mediated cleavage of G3BP1. Meanwhile, TIA1-
containing foci devoid of other SG-defining components,
such as initiation factors and most mRNAs were observed
late post-infection. Some viruses, e.g., West Nile virus
(WNV), dengue virus (DV), rhesus rotavirus (RRV), type
1 human T-cell leukemia viruses (HTLV-1), and human
immunodeficiency viruses (HIV) were found to be able to
suppress SG formation [5-7]. Cardioviruses with mutant
leader (L) proteins, such as Theiler’s murine encephalomy-
elitis virus (TMEV), encephalomyocarditis virus (EMCV)
and Saffold virus (SAFV) induce SG formation throughout
the infection, while expression of the L protein during in-
fection efficiently blocks SG formation. Similarly, influ-
enza A virus (IAV) infection fails to induce SGs unless
viruses with NS1 mutations are used [5-9]. In some cases,
SGs play an important role in host antiviral defense, e.g.,
IAV, MRV and vaccinia virus (VV). However, SGs induced
by RSV can promote virus replication [5-7].
Group B coxsackieviruses (CVBs) are the major patho-
gens of human viral myocarditis and dilated cardiomyop-
athy [10,11]. Enterovirus 71 (EV71) is the major pathogen
of human hand, foot, and mouth disease (HFMD) [12].
Both CVBs and EV71 belong to the enterovirus genus of
the Picornaviridae family. The picornavirus genome is a
~7.0-kb-to-8.5-kb single-stranded positive-sense RNA
(+ssRNA) that is composed of a single open reading frame
(ORF) and two untranslated regions (UTRs) at its 5′ and
3′ flanks. The genome can act as an mRNA encoding a
polyprotein that is proteolytically processed by viral pro-
teinases into structural and nonstructural proteins [13].
Picornaviruses induce multiple alterations in host cells to
facilitate its replication. Suppressing cellular biosynthesis
by viral proteinases 2A (2Apro) and 3C (3Cpro) is one of
the most notable alterations [13-17]. Upon the cleavage of
eIF4G, eIF5B, and PABP by 3Cpro and 2Apro, picornavi-
ruses can shut off cap-dependent translation and termin-
ate cellular biosynthesis [13-17]. In addition, through the
cleavage of nuclear pore complex proteins (Nups), 2Apro
can alter RNA and protein trafficking between the nucleus
and cytoplasm [13]. A recent report shows that 2Apro of
PV, a member of Picornaviridae, can cause a dramatic
nuclear-cytoplasm re-localization of SRp20, a cellular spli-
cing factor that is also defined as an IRES trans-acting fac-
tor (ITAF) [18].
Recent studies indicate that PV induces unique SGs in
infected cells [19-21]. The PV-induced SGs contain cer-
tain components that do not localize to SGs induced by
oxidative stress, e.g., Sam68 and SRp20 [20,22]. However,
the exact mechanism by which the picornavirus induces
SG formation is unknown. In this study, we confirmed
that CVB type 3 (CVB3) and EV71 also induce SGformation. We found that 2Apro plays a crucial role in
SG induction because 2Apro alone is sufficient to trigger
SG formation. Our findings may help us to better
understand the mechanism by which picornaviruses ini-
tiate SG formation.
Results
CVB3 infection induces SG formation
To facilitate observing SG formation during CVB3 infec-
tion, we constructed a HeLa cell line (HeLaEGFP-TIA1),
constitutively expressing EGFP-TIA1. SG formation was
first determined by observing the expression and
localization of TIA1 and HuR. HeLaEGFP-TIA1 cells were
infected with CVB3 (MOI = 10) or treated with 0.5 mM
NaArs for 30 min. In the mock-treated cells, EGFP-TIA1
was distributed in both the cytoplasm and nucleus. In the
Ars-treated and CVB3-infected cells, EGFP-TIA1 was
granularly distributed in the cytoplasm. The granules
began to emerge in the cytoplasm of the CVB3-infected
cells at 3 h post-infection (p.i.) (Figure 1).
Using an anti-HuR or anti-G3BP1 antibody, we found
that HuR was predominantly localized in the nucleus of
the mock-infected cells, but it re-localized to the cytoplas-
mic granules after both Ars treatment and CVB3 infection
(Figure 1A). G3BP1 was distributed evenly in the cyto-
plasm of the mock-infected cells but formed granules in
the CVB3-infected cells at 3 h p.i. but the G3BP1-positive
granules dispersed at 6 h p.i. (Figure 1B). EGFP-TIA1 and
HuR were co-localized in the granules in Ars-treated and
CVB3-infected cells (Figure 1A). G3BP1 was also co-
localized with EGFP-TIA1 in the granules of Ars-treated
(data not shown) and CVB3-infected cells (Figure 1B).
Furthermore, in HeLa cells co-transfected with
pEGFP-eIF4G and pmCherry-HuR, both mCherry-HuR
and EGFP-eIF4G re-located from the nucleus to the cyto-
plasmic granules after CVB3 infection (MOI = 10) for 3 h
(Figure 1C). We also noticed that the SGs contained HuR
but no eIF4G at 6 h p.i. (Figure 1C). These data demon-
strate that CVB3 induced typical SGs.
2Apro is the key protein that triggers SG formation
To identify the viral component that triggered SG for-
mation during CVB3 infection, HeLa cells were co-
transfected with pmCherry-HuR and one of the nine
plasmids expressing EGFP-tagged viral proteins (VP1,
VP4-3, 2Apro, 2B, 2C, 3A, 3B, 3Cpro, and 3D). We ob-
served that mCherry-HuR was translocated from the nu-
cleus to the cytoplasmic granules in cells transfected with
pEGFP-2A after 24 h post-transfection (Figure 2A). We
observed a similar result in Vero cells (Additional file 1:
Figure S1). The nuclear localization of mCherry-HuR was
not affected in cells expressing EGFP, VP1, VP4-3, 2B, 2C,
3A, 3B, 3Cpro, or 3D (Figure 2A). Quantification of these
experiments indicated that 93% (±2% [standard deviation])
Figure 1 CVB3 infection induces SG formation. (A) HeLaEGFP-TIA1 cells were mock infected, exposed to 0.5 mM NaArs for 30 min, or infected
with CVB3 (MOI =10) for 3 h. The cells were then fixed and stained for HuR. (B) HeLaEGFP-TIA1 cells were infected with CVB3 as discribed in (A). The cells
were then fixed and stained for G3BP1. (C) HeLa cells, co-transfected with pEGFP-eIF4G and pmCherry-HuR, were infected with CVB3 as discribed in
(A). The cells were then fixed and imaged. Nuclei were identified by Hoechst 33342 staining. Cells were examined using a fluorescence microscopy (×400).
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the percentages of SGs in other groups of cells did not
exceed 5%.By monitoring the endogenous HuR distribution using
the anti-HuR antibody, a similar result was observed in
cells only transfected with the viral protein-expressing
Figure 2 CVB3 2Apro is identified as the viral component that induces SG formation in HeLa cells. (A) HeLa cells were co-transfected with
the pmCherry-HuR plasmid and one of the following plasmids: pEGFP-2A, pEGFP-2B, pEGFP-2C, pEGFP-3A, pEGFP-3B, pEGFP-3C, pEGFP-3D,
pEGFP-VP1, or pEGFP-VP4-3. At 24 h post-transfection, the cells were imaged. The quantification of SG formation for each group was determined
by analyzing the percentage of EGFP-expressing cells that contained three or more granules. At least 100 cells were counted for each experiment.
The average of three independent experiments is indicated on the lower part of each panel. (B) HeLa cells were transfected with pEGFP-C1,
pEGFP-2A, or pEGFP-3C. The cells were then fixed at 24 h post-transfection and stained for HuR via an anti-HuR rabbit polyclonal antibody and a
CF555-labeled goat anti-rabbit secondary antibody. (C) HeLa cells were treated as discribed in (B) and then stained for G3BP1 via an anti-G3BP1
mouse monoclonal antibody and a CF555-labeled goat anti-mouse secondary antibody. Hoechst 33342 was used to counterstain the nuclei. The
SGs were determined by observing the granular distribution of mCherry-HuR (A), HuR (B), and G3BP1 (C) in the cytoplasm under a fluorescence
microscope (×400). The cytoplasmic granules are indicated by arrow heads.
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that G3BP1 was distributed in cytoplasmic granules only
in the cells expressing 2Apro (Figure 2C). These results
imply that 2Apro is the key viral component that triggers
SG formation during CVB3 infection.
The protease activity is necessary for 2Apro to trigger SG
formation
Because the amino acid sequences of CVB3 2Apro and PV
2Apro were highly homologous (Figure 3), eight EGFP-
tagged CVB3 2Apro mutants including D39E, L40F, S67F,Y89L, Y90L, V120M, G122E, and D136N (marked with
asterisks in Figure 3) were generated according to the PV
2Apro variants that exhibited different cleavage activity to-
ward eIF4G (Additional file 1: Table S4). Their protease
activities, as indicated by their efficiency in cleaving eIF4G
[23-25], were evaluated. Table 1 shows the results of their
assessment of eIF4G cleavage activity. In cells expressing
these mutants, only 2AG122E showed attenuated protease
activity compared with the prototype (Figure 4C and
Table 1). The mutants including L40F, S67F, V120M,
G122E, and D136N behaved as expected [24,25], while the
Figure 3 Amino acid alignment of 2Apro in PV and CVB3. Identical residues are in white lettering on a black background. The residues marked
with asterisks (*) represent the amino acids of CVB3 2Apro that would be mutated according to Additional file 1: Table S4.
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as expected [23].
To determine whether the proteinase activity of 2Apro is
required for SG formation, HeLa cells were co-transfected
with pmCherry-HuR and each of the mutant-expressing
plasmids. We found that only a few SGs were formed in
cells expressing 2AG122E. In contrast, there were abundant
SGs formed in the cells expressing other 2Apro mutants
(Figure 4A). Quantitative analysis of these data revealed
that only 7% (±3%) of EGFP-2AG122E-expressing cells con-
tained SGs and over 90% of cells expressing the other 2A
mutants remained positive for SGs. Similar results were
observed for G3BP1 as the SG marker (Figure 4B). There-
fore, we concluded that the protease activity was required
for 2Apro to induce SGs.
EV71 and its 2Apro also induce SG formation
We next examined whether SGs formed in cells infected
with EV71. HeLaEGFP-TIA1 cells were mock-infected or in-
fected with EV71 at an MOI of 10. In the infected cells,Table 1 The eIF4G cleavage activity obtained with
different variants of CVB3 2Apro
2A mutant eIF4G cleavage activity*
Wild-type + + +
D39E + + +
L40F + + +
S67F + +
Y89L + + +
Y90L + +
V120M + + +
G122E +/−
D136N + + +
*The 2A protease activity was determined to be undetectable (−), detectable
in some assays (+/−), or positive (+ to + + +).both EGFP-TIA1 and HuR underwent redistribution and
co-localized to the cytoplasmic granules (Figure 5A). At
3 h p.i., approximately 34% of the infected cells showed
granules. The granules also contained G3BP1 and eIF4G
(data not shown), indicating that EV71 infection also
induced SG formation. Similar to the experiments de-
scribed in the previous section, HeLa cells were also
co-transfected with pmCherry-HuR and pEGFP-C1 or
pEGFP-EV71 2A. We found that 91% (±4%) of EV71
2Apro-expressed cells were positive for SGs (Figure 5B).
A similar result was obtained in the infected Vero cells
(Additional file 1: Figure S1). Thus, EV71 2Apro can
function in SG formation.
Discussion
The interaction between viruses and host cells is critical
for understanding the pathogenesis of viral infections.
SG formation is one of the remarkable cellular events
when cells sense an unfavorable stimulation [1,2]. Mul-
tiple viruses interact with SGs in different ways [5-7]. It
has been reported that PV can induce SG formation.
CVB3, EV71, and PV are members of the genus Entero-
virus; however, they cause completely different types of
diseases [10,12,26]. In this study, we found that CVB3
and EV71 could efficiently induce SG formation. The
2Apro of both viruses were identified as the key for trig-
gering SG formation. Our findings may help us to better
understand the mechanism by which the picornaviruses
initiate SG formation.
According to previous studies, TIA1, HuR, G3BP1,
and eIF4G were chosen as the SG markers for our ob-
servations. TIA1 and HuR have been shown to be con-
stantly recruited to SGs during PV infection, while
G3BP1 and eIF4G can be detected in SGs at the early
stage of the PV infection, but not later [19-21]. To facili-
tate observing the effect of virus on SG formation, we
Figure 4 The protease activity is required for 2Apro to induce SGs. (A) HeLa cells were co-transfected with pmCherry-HuR and one of the
plasmids (pEGFP-2AD39E, pEGFP-2AL40F, pEGFP-2AS67F, pEGFP-2AY89L, pEGFP-2AY90L, pEGFP-2AV120M, pEGFP-2AG122E, or pEGFP-2AD136N). The cells
were observed at 24 h post-transfection. The percentage of EGFP-expressing cells with granules was quantified as in Figure 2A. The average of
three independent experiments is indicated on the lower right of each panel. (B) HeLa cells were transfected with pEGFP-C1, or pEGFP-2AG122E.
The cells were fixed at 24 h post-transfection and then stained for G3BP1. Nuclei were identified by Hoechst 33342 staining. The localization of
the mCherry-HuR (A) or G3BP1 (B) proteins was determined using a fluorescence microscope (×400). (C) The protease activity of the 2Apro mutants
based on the cleavage efficiency of eIF4G was determined. HeLa cells were transfected with these 2Apro mutant-expressing plasmids and the integrity
of eIF4G was detected by western blotting at 24 h post-transfection.
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expressing TIA1. EGFP-TIA1 was distributed in cytoplas-
mic granules in CVB3- and EV71-infected HeLaEGFP-TIA1
cells (Figures 1 and 4). The granules were further con-
firmed as SGs because HuR, G3BP1, and eIF4G were also
found in the granules (Figure 1). The SGs emerged as
early as 3 h after the cells were infected with CVB3 or
EV71 (MOI = 10) (Figures 1 and 5), suggesting that CVB3
and EV71 may efficiently induce SG formation. We alsoobserved that G3BP1 and eIF4G were not localized to the
SGs at the late stages of CVB3 or EV71 infection (data not
shown), which was similar to the results during PV infec-
tion [19,21]. Thus, it is likely that SG formation may be
a common feature in the response to picornavirus
infections.
It would be interesting to know how picornaviruses ini-
tiate SG formation. SG formation may be triggered dir-
ectly by a single viral component, or it could be indirectly
Figure 5 EV71 and its 2Apro also induce SG formation. (A) HeLaEGFP-TIA1 cells were mock-infected, or infected with EV71 (MOI =10) for 3 h.
After fixation, the cells were stained for HuR. The quantification of SG formation was determined by analyzing more than 100 cells that contained
three or more granules in multiple fields for each experiment. The average of three independent experiments is indicated on the lower right of each
panel. (B) HeLa cells were co-transfected with pmCherry-HuR and pEGFP-EV71 2A or pEGFP-C1 and the cells were fixed at 24 h post-transfection and
then imaged. Nuclei were stained with Hoechst 33342. The localization of EGFP-TIA1 (A), HuR (A), or mCherry-HuR (B) was determined under
a fluorescence microscope (×400). The percentage of green cells possessing SGs was quantified as in Figure 2A.
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picornavirus infections occur. Upon observation of the
cellular response to every CVB3 protein, SGs traced by
mCherry-HuR or endogenous HuR could only be viewed
in cells expressing 2Apro (Figure 2). HuR dominantly local-
izes in the nucleus. It is known that 2Apro can disturb the
nucleus-cytoplasm trafficking of macromolecules through
cleaving nuclear pore proteins [13]. Thus, the translocali-
zation of HuR may be a consequence of the nucleus-
cytoplasm trafficking malfunction caused by 2Apro. For
this reason, we validated our observation using the cyto-
plasmic SG marker G3BP1. Interestingly, G3BP1-labeled
SGs could also only be viewed in cells expressing 2Apro
(Figure 2).
To further verify the role of 2Apro in SG formation, we
generated eight 2Apro mutants based on studies of PV
2Apro [20,21,23]. Among them, the protease activity of
2AG122E was attenuated shown by measuring the cleavage
efficiency of eIF4G. Accordingly, 2AG122E did not induce
SG formation, indicating that the protease activity was re-
quired for 2Apro to trigger SG formation (Figure 4). Our
results suggest that 2Apro may be the key viral protein of
CVB3 and EV71 to induce SG formation.
The role of 2Apro in SG formation may be similar in PV
infection. A recent study showed that PV infection could
cause the redistribution of SRp20, a nucleocytoplasmic
shuttling splicing factor [18]. The ectopic expression of
PV 2Apro was sufficient to cause the re-localization ofSRp20 from the nucleus to the cytoplasmic granules [18].
A later study demonstrated that SRp20 could co-localize
with TIA1 in the cytoplasmic granules of PV-infected
cells, suggesting that SRp20 might also be a SG compo-
nent [22]. These observations provide extra evidence for
the role of 2Apro in SG formation during picornavirus
infections.
In summary, our findings help us to better understand
the mechanism by which picornaviruses initiate SG for-
mation in infected cells. However, the cellular compo-
nents that 2Apro targets to trigger SG formation remain
unknown. Further study is needed to identify these tar-
gets to elucidate this cellular event.
Conclusion
In this study, we demonstrated that both CVB3 and
EV71 infections can induce SG formation and that 2Apro
plays a crucial role in the induction of SG formation
during these infections. The protease activity was neces-
sary for 2Apro to trigger SG formation. This novel find-
ing may help us to better understand the mechanism by
which picornaviruses initiate the SG response.
Methods
Cell lines and viruses
HeLa cells were grown in Dulbecco’s modified Eagle
medium (DMEM) (Invitrogen, Carlsbad, CA) supple-
mented with 8% (growth medium) or 5% (maintaining
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tries Israel). A HeLa cell line stably expressing EGFP-
TIA1 was established as described previously [27].
HeLa cells were cultured in 12-well plates to approxi-
mately 60% confluence and transfected with the plasmid
pEGFP-TIA1 using Lipofectamine 2000 (Invitrogen). Cells
were then grown in medium containing G418 (500 μg/
ml). We replaced the culture medium every 2 days
until colonies were observed. We acquired the stable
cell line HeLaEGFP-TIA1 through 8 weeks of selection.
HeLaEGFP-TIA1 cells stably expressing EGFP-TIA1 were
grown in DMEM containing 10% FBS and 500 μg/ml G418.
The CVB3 Woodruff strain was passaged in HeLa cells
and titered by plaque assays as described previously [28].
The EV71 BrCr strain was passaged in Vero cells and ti-
trated using the 50% tissue culture infective dose (TCID50)
assay as described in our previous research [29].
Plasmid construction
The plasmid expressing EGFP-tagged TIA1 or eIF4G was
constructed in our laboratory. First, the EGFP-coding
sequence was obtained from pEGFP-N1 (Clontech,
Mountain View, CA) by polymerase chain reaction (PCR).
The pcDNA3.1 (Invitrogen) and EGFP amplicons were
digested by Nhe I and Hind III and then ligated at 16°C
overnight with T4 ligase. The obtained plasmid was desig-
nated as pEGFP-C1. TIA1 and eIF4G cDNAs were ampli-
fied by reverse transcription PCR (RT-PCR) from the
RNA extracts prepared from HeLa cells using TRIzol re-
agents (Invitrogen) and then cloned into pEGFP-C1. The
resulting plasmids were designated as pEGFP-TIA1 and
pEGFP-eIF4G, respectively. Similarly, the pmCherry-HuR
plasmid, encoding a fusion protein of HuR and red fluor-
escence protein mCherry, was constructed based on
pmCherry-C1 (Clontech). The plasmids were confirmed
by DNA sequencing. The primers for the amplifications
are listed in Additional file 1: Table S1.
Nine plasmids expressing EGFP-tagged VP1, VP4-
VP2-VP3, 2Apro, 2B, 2C, 3A, 3B, 3Cpro, or 3D of CVB3
were constructed as described previously [28,30] and
designated as pEGFP-VP1, pEGFP-VP4-3, pEGFP-2A,
pEGFP-2B, pEGFP-2C, pEGFP-3A, pEGFP-3B, pEGFP-
3C, and pEGFP-3D, respectively. The primers are listed
in Additional file 1: Table S2 and Table S3.
Site-directed mutagenesis
Eight mutants of CVB3 2Apro, including 2AD39E, 2AL40F,
2AS67F, 2AY89L, 2AY90L, 2AV120M, 2AG122E and 2AD136N,
were generated by overlap PCR. Briefly, to generate
2AD39E, the pEGFP-2A DNA was amplified with 2A sense
primer and 2AD39E antisense primer, and with 2AD39E
sense primer and 2A antisense primer, respectively
(Additional file 1: Table S3). The PCR products were puri-
fied and mixed together. The mixture was amplified with2A sense and antisense primers. The resultant DNA was
digested with Hind III and Xba I and inserted into the
cloning site of pEGFP-C1. These plasmids were desig-
nated as pEGFP-2AD39E, pEGFP-2AL40F, pEGFP-2AS67F,
pEGFP-2AY89L, pEGFP-2AY90L, pEGFP-2AV120M, pEGFP-
2AG122E, and pEGFP-2AD136N, respectively. The digested
fragments were mixed and ligated to pEGFP-C1/Hind III +
Xba I. All plasmids were confirmed by DNA sequencing.
Transfection
For virus infection, HeLa cells were seeded in 24-well
plates and grown to approximately 60% confluence. The
cells were then co-transfected with 0.1 μg pmCherry-
HuR and 0.5 μg pEGFP-C1, or pEGFP-eIF4G using 1 μl
Lipofectamine 2000 (Invitrogen) per well. To express the
viral proteins, cells were seeded in 24-well plates and
grown to approximately 70% confluence. Cells were then
co-transfected with 0.3 μg pmCherry-HuR and 0.3 μg
plasmid encoding EGFP-tagged CVB3 2Apro, 2B, 2C, 3A,
3B, 3Cpro, 3D, VP1, VP4-VP2-VP3, 2AD39E, 2AL40F,
2AS67F, 2AY89L, 2AY90L, 2AV120M, 2AG122E, or 2AD136N;
EV71 2Apro; or the empty vector pEGFP-C1. Five hours
later, the culture media were removed and replaced with
fresh media. Images were taken using an Axiovert 200
fluorescence microscope (Carl Zeiss, Gottingen, Germany)
at 24 h post-transfection. Some cells were seeded in 48-
well plates and transfected with plasmid encoding EGFP-
tagged CVB3 2Apro, 2AG122E or 3Cpro. Control cells were
transfected with pEGFP-C1. After 24 h post-transfection,
the cells were fixed for immunofluorescence assay of HuR
and G3BP1. To investigate eIF4G cleavage, HeLa cells
were transfected with plasmid encoding EGFP-tagged
CVB3 2Apro, 2AD39E, 2AL40F, 2AS67F, 2AY89L, 2AY90L,
2AV120M, 2AG122E or 2AD136N. Cells were harvested at
24 h post-transfection. Whole-cell lysates were subjected
to sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE) and western blotting analysis.
Virus infection
HeLaEGFP-TIA1 cells were mock-infected, or infected with
CVB3 or EV71 at a multiplication of infection (MOI) of
10. At 3 h p.i., HeLaEGFP-TIA1 cells were fixed for im-
munofluorescence assays. HeLa cells, co-transfected
with pmCherry-HuR and pEGFP-C1, or pEGFP-eIF4G
or pEGFP-eIF4GG681E, were mock-infected or infected
with CVB3 (MOI = 10). At 3, 4, or 6 h p.i., the cells were
washed once with phosphate-buffered saline (PBS), and
processed for imaging using an Axiovert 200 fluores-
cence microscope.
Arsenite (Ars) treatment
Ars has been widely used as a stimulator of SGs [2]. To
induce SGs, cells were treated with sodium arsenite
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tion of 0.5 mM in growth medium for 30 min.
Immunofluorescence
Following virus infection, Ars treatment, or plasmid trans-
fection as described above, the cells were washed once with
PBS and then fixed with 4% paraformaldehyde at room
temperature for 30 min. The cells were treated with 0.25%
Triton X-100 for 10 min and blocked with PBS containing
1% bovine serum albumin (BSA) for 30 min at room
temperature. Cells were then incubated overnight at 4°C
with primary antibody diluted in blocking buffer and with
secondary antibody for 2 h at room temperature in the
dark. G3BP1 was detected via a monoclonal anti-G3BP1
antibody (611126, BD Transduction Labs, San Jose, CA) at
a dilution of 1:200 and a CF555-labeled goat anti-mouse
secondary antibody (20231, Biotium, Hayward, CA) at a di-
lution of 1:1000. HuR was detected via a polyclonal anti-
body (11910-1-AP, Proteintech Group Inc., Chicago, IL) at
a dilution of 1:200 and a CF555-labeled anti-rabbit second-
ary antibody (20232, Biotium) at a dilution of 1:1000. The
cells were then washed three times with PBS and stained
with Hoechst 33342 (0.4 μg/ml in PBS). Images were taken
using an Axiovert 200 fluorescence microscope.
Western blotting
Proteins were extracted from the treated cells using Pierce
RIPA Buffer with PMSF cocktail. Approximately 2 μg of
the extracted proteins were applied to SDS-PAGE. The
separated proteins were transferred to a polyvinylidene
fluoride (PVDF) membrane (0.45 μm, Millipore, Billerica,
MA), which was blocked with 5% nonfat milk for 2 h at
37°C and incubated with primary antibody overnight at
4°C. A polyclonal rabbit anti-eIF4G antibody (15704-1-AP,
Proteintech Group Inc.) was 1:1000 diluted to detect
eIF4G; a polyclonal anti-β-actin antibody (sc-130301, Santa
Cruz Biotechnology, SantaCruz, CA) was 1:1000 diluted to
detect β-actin. After a standard washing, the membrane
was incubated with horse radish peroxidase (HRP)-labeled
secondary antibody (Zhongshan Goldenbridge Biotech,
Beijing, China) for 1 h at room temperature and washed
again. The blots were stained using Super Signal kit
(Pierce, Rockford, IL) and imaged by a LAS4000 charge-
coupled camera (Fujifilm, Tokyo, Japan). The β-actin was
employed as a loading control.
Additional file
Additional file 1: Table S1. PCR primers for the construction of plasmids
pEGFP-C1, pEGFP-TIA1, pmCherry-HuR , pEGFP-eIF4G and pEGFP-eIF4GG681E.
Table S2. PCR primers for the construction of plasmids expressing CVB3
protein 2B, 3A, 3B, 3C, and 3D. Table S3. PCR primer sequences used for
the site-directed mutagenesis of 2Apro. Table S4. The eIF4G cleavage activity
obtained with different variants of PV 2Apro [23-25]. Figure S1. Expression of
CVB3 2Apro or EV71 2Apro in Vero cells results in SG formation. Vero cellswere co-transfected with pmCherry-HuR and pEGFP-C1 or pEGFP-CVB3 2A
or pEGFP-EV71 2A. Nuclei were identified by Hoechst 33342. The 2A
expression and mCherry-HuR-positive SGs were determined using a
fluorescence microscope (× 400) at 24 h post-transfection.
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